Firocoxib

Verify with FDA CVM →

3,499 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
3,499
Total Reports
560
Deaths Reported
1600.0%
Death Rate

Active Ingredients

Firocoxib

Administration Routes

OralUnknownIntravenousSubcutaneousIntraocularOtherIntramuscularTopical

Species Affected

Dog 2,731
Unknown 395
Horse 334
Cat 20
Human 13
Mule 3
Other 2
Donkey 1

Most Affected Breeds

Retriever - Labrador 454
Unknown 426
Crossbred Canine/dog 289
Dog (unknown) 209
Retriever - Golden 158
Shepherd Dog - German 122
Boxer (German Boxer) 99
Quarter Horse 93
Rottweiler 85
Horse (unknown) 73

Most Reported Reactions

Vomiting 870
Anorexia 449
Diarrhoea 389
Elevated blood urea nitrogen (BUN) 350
Lethargy (see also Central nervous system depression in 'Neurological') 307
Death 279
Elevated creatinine 273
Death by euthanasia 263
Elevated serum alkaline phosphatase (SAP) 227
Other abnormal test result NOS 218
Elevated alanine aminotransferase (ALT) 215
Depression 202

Outcome Breakdown

Outcome Unknown
853 (36.7%)
Recovered/Normal
557 (24.0%)
Died
394 (17.0%)
Ongoing
333 (14.3%)
Euthanized
166 (7.1%)
Recovered with Sequela
20 (0.9%)

Data Summary

Metric Value
Total adverse event reports 3,499
Reports involving death 560
Case-fatality rate (reported events) 1600.0%
Distinct species in reports 8
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Firocoxib Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 3,499 adverse event reports referencing Firocoxib, including 560 reports in which the animal died — a 1600.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Firocoxib. Reported administration routes include Oral, Unknown, Intravenous, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Firocoxib reports are Dog (2,731 reports), Unknown (395 reports), Horse (334 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (454), Unknown (426), Crossbred Canine/dog (289) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Firocoxib are Vomiting (870), Anorexia (449), Diarrhoea (389), Elevated blood urea nitrogen (BUN) (350). Of the 2,323 reports with a coded outcome, Outcome Unknown is the leading category at 36.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Firocoxib.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial